🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06493994
Recruiting Observational

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

NCT06493994 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2025-01-01
Last updated
2025-01-03

Condition(s) studied

Aortic Valve Stenosis

Investigational drug(s) / intervention(s)

transaxillary (TAX) transcatheter aortic valve replacement

transaxillary (TAX) transcatheter aortic valve replacement: Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Study summary

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement * BMI \<35 kg/m2 * Ability to give informed consent Exclusion Criteria: * History of coronary artery bypass graft and a patent left internal mammary artery (LIMA) * Age ≤18 years * Patients presenting with pregnancy * Patients without informed consent * Expected life expectancy \<2 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universität zu Lübeck Lübeck Schleswig-Holstein Recruiting

More University of Luebeck trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06493994 on ClinicalTrials.gov ↗ ← All trials in Germany